Evidence that duplications of 22q11.2 protect against schizophrenia.

A number of large, rare copy number variants (CNVs) are deleterious for neurodevelopmental disorders, but large, rare, protective CNVs have not been reported for such phenotypes. Here we show in a CNV analysis of 47 005 individuals, the largest CNV analysis of schizophrenia to date, that large duplications (1.5-3.0 Mb) at 22q11.2--the reciprocal of the well-known, risk-inducing deletion of this locus--are substantially less common in schizophrenia cases than in the general population (0.014% vs 0.085%, OR=0.17, P=0.00086). 22q11.2 duplications represent the first putative protective mutation for schizophrenia.

GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia.

We conducted data-mining analyses using the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and molecular genetics of schizophrenia genome-wide association study supported by the genetic association information network (MGS-GAIN) schizophrenia data sets and performed bioinformatic prioritization for all the markers with P-values ≤0.05 in both data sets. In this process, we found that in the CMYA5 gene, there were two non-synonymous markers, rs3828611 and rs10043986, showing nominal significance in both the CATIE and MGS-GAIN samples. In a combined analysis of both the CATIE and MGS-GAIN samples, rs4704591 was identified as the most significant marker in the gene. Linkage disequilibrium analyses indicated that these markers were in low LD (3 828 611-rs10043986, r(2)=0.008; rs10043986-rs4704591, r(2)=0.204). In addition, CMYA5 was reported to be physically interacting with the DTNBP1 gene, a promising candidate for schizophrenia, suggesting that CMYA5 may be involved in the same biological pathway and process. On the basis of this information, we performed replication studies for these three single-nucleotide polymorphisms. The rs3828611 was found to have conflicting results in our Irish samples and was dropped out without further investigation. The other two markers were verified in 23 other independent data sets. In a meta-analysis of all 23 replication samples (family samples, 912 families with 4160 subjects; case-control samples, 11 380 cases and 15 021 controls), we found that both markers are significantly associated with schizophrenia (rs10043986, odds ratio (OR)=1.11, 95% confidence interval (CI)=1.04-1.18, P=8.2 × 10(-4) and rs4704591, OR=1.07, 95% CI=1.03-1.11, P=3.0 × 10(-4)). The results were also significant for the 22 Caucasian replication samples (rs10043986, OR=1.11, 95% CI=1.03-1.17, P=0.0026 and rs4704591, OR=1.07, 95% CI=1.02-1.11, P=0.0015). Furthermore, haplotype conditioned analyses indicated that the association signals observed at these two markers are independent. On the basis of these results, we concluded that CMYA5 is associated with schizophrenia and further investigation of the gene is warranted.

Deformations of the Tracy-Widom distribution.

In random matrix theory, the Tracy-Widom (TW) distribution describes the behavior of the largest eigenvalue. We consider here two models in which TW undergoes transformations. In the first one disorder is introduced in the Gaussian ensembles by superimposing an external source of randomness. A competition between TW and a normal (Gaussian) distribution results, depending on the spreading of the disorder. The second model consists of removing at random a fraction of (correlated) eigenvalues of a random matrix. The usual formalism of Fredholm determinants extends naturally. A continuous transition from TW to the Weilbull distribution, characteristic of extreme values of an uncorrelated sequence, is obtained.

Disordered ensembles of random matrices.

It is shown that the families of generalized matrix ensembles recently considered which give rise to an orthogonal invariant stable Lévy ensemble can be generated by the simple procedure of dividing Gaussian matrices by a random variable. The nonergodicity of this kind of disordered ensembles is investigated. It is shown that the same procedure applied to random graphs gives rise to a family that interpolates between the Erdös-Renyi and the scale free models.

Missing levels in acoustic resonators.

It is shown that the deviations of the experimental statistics of six chaotic acoustic resonators from Wigner-Dyson random matrix theory predictions are explained by a recent model of random missing levels. In these resonatorsa made of aluminum plates a the larger deviations occur in the spectral rigidity (SRs) while the nearest-neighbor distributions (NNDs) are still close to the Wigner surmise. Good fits to the experimental NNDs and SRs are obtained by adjusting only one parameter, which is the fraction of remaining levels of the complete spectra. For two Sinai stadiums, one Sinai stadium without planar symmetry, two triangles, and a sixth of the three-leaf clover shapes, was found that 7%, 4%, 7%, and 2%, respectively, of eigenfrequencies were not detected.

Finite element studies of the deformation of the pelvic floor.

This article describes research involving finite element simulations of women's pelvic floor, undertaken in the engineering schools of Lisbon and Oporto, in collaboration with the medical school of Oporto. These studies are motivated by the pelvic floor dysfunctions that lead namely to urinary incontinence and pelvic organ prolapse. This research ultimately aims at: (i) contributing to clarify the primary mechanism behind such disorders; (ii) providing tools to simulate the pelvic floor function and the effects of its dysfunctions; (iii) contributing to planning and performing surgeries in a more controlled and reliable way. The finite element meshes of the levator ani are based on a publicly available geometric data set, and use triangular thin shell or special brick elements. Muscle and soft tissues are assumed as (quasi-)incompressible hyperelastic materials. Skeletal muscles are transversely isotropic with a single fiber direction, embedded in an isotropic matrix. The fibers considered in this work may be purely passive, or active with input of neuronal excitation and consideration of the muscle activation process. The first assumption may be adequate to simulate passive deformations of the pelvic muscles and tissues (namely, under the extreme loading conditions of childbirth). The latter may be adequate to model faster contractions that occur in time intervals of the same order as those of muscle activation and deactivation (as in preventing urinary incontinence in coughing or sneezing). Numerical simulations are presented for the active deformation of the levator ani muscle under constant pressure and neural excitation, and for the deformation induced by a vaginal childbirth.

Integrating genetic, functional genomic, and bioinformatics data in a systems biology approach to complex diseases: application to schizophrenia.

The search for DNA alterations that cause human disease has been an area of active research for more than 50 years, since the time that the genetic code was first solved. In the absence of data implicating chromosomal aberrations, researchers historically have performed whole genome linkage analysis or candidate gene association analysis to develop hypotheses about the genes that most likely cause a specific phenotype or disease. Whereas whole genome linkage analysis examines all chromosomal locations without a priori predictions regarding what genes underlie susceptibility, candidate gene association studies require a researcher to know in advance the genes that he or she wishes to test (based on their knowledge of a disease). To date, very few whole genome linkage studies and candidate gene studies have produced results that lead to generalizable findings about common diseases. One factor contributing to this lack of results has certainly been the previously limited resolution of the techniques. Recent technological advances, however, have made it possible to perform highly informative whole genome linkage and association analyses, as well as whole genome transcription (transcriptome) analysis. In addition, for the first time we can detect structural DNA aberrations throughout the genome on a fine scale. Each of these four approaches has its own strengths and weaknesses, but taken together, the results from an integrated analysis can implicate highly promising novel candidate genes. Here, we provide an overview of the integrated methodology that we have used to combine high-throughput genetic and functional genomic data with bioinformatics data that have produced new insights into the potential biological basis for schizophrenia. We believe that the potential of this combined approach is greater than that of a single mode of discovery, particularly for complex genetic diseases.

Symmetry-breaking study with deformed ensembles.

A random matrix model to describe the coupling of m -fold symmetry is constructed. The particular threefold case is used to analyze data on eigenfrequencies of elastomechanical vibration of an anisotropic quartz block. It is suggested that such an experimental and theoretical study may supply a powerful means to discern the intrinsic symmetry of physical systems.

Pseudo-Hermitian anti-Hermitian ensemble of Gaussian matrices.

It is shown that the ensemble of pseudo-Hermitian Gaussian matrices recently introduced gives rise in a certain limit to an ensemble of anti-Hermitian matrices whose eigenvalues have properties directly related to those of the chiral ensemble of random matrices.

Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder.

We performed a genome-wide association study of 6447 bipolar disorder (BD) cases and 12 639 controls from the International Cohort Collection for Bipolar Disorder (ICCBD). Meta-analysis was performed with prior results from the Psychiatric Genomics Consortium Bipolar Disorder Working Group for a combined sample of 13 902 cases and 19 279 controls. We identified eight genome-wide significant, associated regions, including a novel associated region on chromosome 10 (rs10884920; P=3.28 × 10-8) that includes the brain-enriched cytoskeleton protein adducin 3 (ADD3), a non-coding RNA, and a neuropeptide-specific aminopeptidase P (XPNPEP1). Our large sample size allowed us to test the heritability and genetic correlation of BD subtypes and investigate their genetic overlap with schizophrenia and major depressive disorder. We found a significant difference in heritability of the two most common forms of BD (BD I SNP-h2=0.35; BD II SNP-h2=0.25; P=0.02). The genetic correlation between BD I and BD II was 0.78, whereas the genetic correlation was 0.97 when BD cohorts containing both types were compared. In addition, we demonstrated a significantly greater load of polygenic risk alleles for schizophrenia and BD in patients with BD I compared with patients with BD II, and a greater load of schizophrenia risk alleles in patients with the bipolar type of schizoaffective disorder compared with patients with either BD I or BD II. These results point to a partial difference in the genetic architecture of BD subtypes as currently defined.

Randomly incomplete spectra and intermediate statistics.

By randomly removing a fraction of levels from a given spectrum a model is constructed that describes a crossover from this spectrum to a Poisson spectrum. The formalism is applied to the transitions towards Poisson from random matrix theory (RMT) spectra and picket fence spectra. It is shown that the Fredholm determinant formalism of RMT extends naturally to describe incomplete RMT spectra.

Pseudo-Hermitian ensemble of random Gaussian matrices.

It is shown how pseudo-Hermiticity, a necessary condition satisfied by operators of PT symmetric systems can be introduced in the three Gaussian classes of random matrix theory. The model describes transitions from real eigenvalues to a situation in which, apart from a residual number, the eigenvalues are complex conjugate.

The F plasmid CcdB protein induces efficient ATP-dependent DNA cleavage by gyrase.

DNA topoisomerases perform essential roles in DNA replication, gene transcription, and chromosome segregation. Recently, we identified a new type of topoisomerase II poison: the CcdB protein of plasmid F. When its action is not prevented by CcdA protein, the CcdB protein is a potent cytotoxin. In this paper, using purified CcdB, CcdA and gyrase, we show that CcdB protein efficiently traps gyrase in a cleavable complex. The CcdA protein not only prevents the gyrase poisoning activity of CcdB but also reverses its effect on gyrase. The mechanism by which the CcdB protein induces DNA strand breakage is closely related to the action of quinolone antibiotics. However, the ATP dependence of the CcdB cleavage process differentiates the CcdB mechanism from quinolone-dependent reactions because the quinolone antibiotics stimulate efficient DNA breakage, whether or not ATP is present. We previously showed that bacteria resistant to quinolone antibiotics are sensitive to CcdB and vice versa. Elucidation of the mechanism of action of CcdB protein may permit the design of drugs targeting gyrase so as to take advantage of this new poisoning mechanism.

Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.

Treatment with fluoxetine hydrochloride was compared with treatment with clomipramine hydrochloride in two groups of patients with obsessive-compulsive disorder using two different experimental designs. In the first group of 11 patients with obsessive-compulsive disorder studied using a randomized, double-blind, crossover design, treatment with fluoxetine for 10 weeks was found to produce therapeutic effects similar to treatment with clomipramine for 10 weeks. There were significantly fewer total side effects reported during fluoxetine than clomipramine treatment. Drug tapering and placebo substitution in the 4-week crossover interval phase led to substantial relapses in obsessive-compulsive disorder symptoms and depression. Furthermore, responses to the second drug took as long to occur as responses to the first drug, although both drugs are thought to act by a common mechanism, serotonin uptake inhibition. A second group of 21 patients with obsessive-compulsive disorder that had been previously stabilized on clomipramine treatment with at least partial benefit were crossed over to fluoxetine treatment in a double-blind fashion. After 10 weeks of fluoxetine administration, most patients manifested behavioral rating scores of obsessive-compulsive disorder and depressive symptoms that were comparable with precrossover ratings completed during clomipramine treatment. A significant exacerbation in obsessive-compulsive disorder and depression ratings as well as a similar lag in therapeutic efficacy were also noted in this second cohort of patients with obsessive-compulsive disorder. Platelet 5-HT concentrations were reduced 95% during both clomipramine and fluoxetine treatment periods. These results suggest that fluoxetine may represent a viable alternative to clomipramine in the treatment of obsessive-compulsive disorder, although further studies with larger sample sizes are needed.

Level density for deformations of the Gaussian orthogonal ensemble.

Formulas are derived for the average level density of deformed, or transition, Gaussian orthogonal random matrix ensembles. After some general considerations about Gaussian ensembles, we derive formulas for the average level density for (i) the transition from the Gaussian orthogonal ensemble (GOE) to the Poisson ensemble and (ii) the transition from the GOE to m GOEs.

Universality of rescaled curvature distributions.

We applied a recently proposed rescaling of curvatures of eigenvalues of parameter-dependent random matrices to experimental data from acoustic systems and to a theoretical result. It is found that the data from four different experiments, ranging from isotropic plates to anisotropic three-dimensional objects, and the theoretical result always agree with the universal curvature distribution, if only the curvatures are rescaled such that the average of their absolute values is unity.

Identification of the bacteriophage D108 kil gene and of the second region of sequence nonhomology with bacteriophage Mu.

To identify the second region of sequence nonhomology between the genomes of the transposable bacteriophages Mu and D108 originally observed by electron-microscopic analysis of DNA heteroduplexes and to localize functions ascribed to the 'accessory' or 'semi-essential' early regions of the phages between genes B and C, a 0.9-kb fragment of each genome located immediately beyond the B gene was cloned and sequenced. Three open reading frames (ORFs) were identified in each. The region of nonhomology is located within the 3' portion of the third ORF. D108 is shown to possess a Kil function similar to that previously shown for Mu, and that function is encoded by the first ORF.

Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.

To evaluate the need for maintenance drug therapy in patients with obsessive-compulsive disorder, the authors assessed 21 patients with obsessive-compulsive disorder who manifested sustained improvement during 5 to 27 months of clomipramine treatment and who agreed to participate in a double-blind discontinuation study. Of 18 patients who completed the study, 16 had substantial recurrence of obsessive-compulsive symptoms by the end of the 7-week placebo period. In addition, 11 had a significant increase in depressive symptoms. Treatment duration before discontinuation of clomipramine was not related to the frequency or severity of obsessive-compulsive or depressive symptom appearance. These findings suggest that prolonged drug treatment may be warranted for obsessive-compulsive disorder.

Obsessive-compulsive disorder in patients with schizophrenia or schizoaffective disorder.

OBJECTIVE: The authors evaluated the frequency of DSM-III-R obsessive-compulsive disorder in patients with a primary diagnosis of schizophrenia or schizoaffective disorder. METHOD: Patients with schizophrenia (N = 52) or schizoaffective disorder (N = 25) were evaluated for the presence of obsessions and compulsions by means of the Structured Clinical Interview for DSM-III-R, the Yale-Brown Obsessive Compulsive Scale, chart review, and contact with the treating clinicians. RESULTS: Six (7.8%) of the 77 patients met the DSM-III-R criteria for both obsessive-compulsive disorder and schizophrenia or schizoaffective disorder. CONCLUSIONS: These findings suggest that obsessive-compulsive disorder occurs in a substantial percentage of patients with schizophrenia or schizoaffective disorder. The addition of medications targeted at obsessive-compulsive disorder may be beneficial to these patients but requires systematic evaluation.

Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.

Eighteen outpatients with obsessive-compulsive disorder were treated with either buspirone, a partial serotonin agonist, or clomipramine, a serotonin uptake inhibitor, in a double-blind, random-assignment study. Both drugs led to statistically significant and similar improvements in scores on the Yale-Brown Obsessive-Compulsive Rating Scale and other obsessive-compulsive and depression scales. This preliminary result warrants further exploration with a larger sample and other serotonergic agents.